The interaction between small doses of dopamine and droperidol on effective renal plasma flow was studied in dogs. Small doses of dopamine are known to produce renal vasodilatation by a dopaminergic mechanism and droperidol, a selective dopamine antagonist used in neuroleptanaesthesia, may attenuate this response. Effective renal plasma flow was measured non-invasively using lU Ihippuran. A 20-min infusion of dopamine 2 \ig kg" 1 min~x significantly enhanced effective renal plasma flow (mean increase of 16%; P<0.05) in anaesthetized dogs. This effect was abolished (mean decrease 6.6%) by droperidol 0.2 mg kg' 1 administered at the commencement of anaesthesia. It is concluded that droperidol reduces the renal vasodilatation induced by dopamine in anaesthetized dogs.
The haemodynamic effects of dopamine are crucially dependent on dose (Goldberg, 1972) . In low doses it has a unique action, increasing renal blood flow via an action on specific dopamine receptors (Yeh, McNay and Goldberg, 1969) . Dopamine is used increasingly for the prophylaxis and treatment of cardiogenic shock following open-heart surgery (Holtzer et al., 1973; Daenen, de Leval and Stark, 1977; Hess et al., 1979) .
The butyrophenone, droperidol, is frequently used in anaesthesia, including that for open-heart surgery (Whitwam and Russell, 1971 ) and drugs in this class are known to be selective dopamine antagonists (Anden et al., 1970) . This study was undertaken to determine whether the response of the renal vasculature to a small dose of dopamine could be affected by a clinically acceptable dose of droperidol administered some hours before the dopamine.
A variety of factors affect renal blood flow other than those which were the subject of the study (Papper and Papper, 1964) . In order to minimize these effects, it was considered necessary to use each subject as its own control. As this involved four separate experiments, dogs rather than humans were used in the investigation.
METHODS
Six beagle dogs (8-16 kg) were studied. Anaesthesia was induced with pentobarbitone sodium 30 rag kg" 1 i.v., the trachea was intubated and the lungs ventilated artificially to normocarbia. Anaesthesia was main- tained with 60% nitrous oxide in oxygen and incremental doses of fentanyl 25 y.g i.v. as needed.
The bladder was catheterized and the dog placed prone on a warming blanket. Rectal temperature and e.c.g. were monitored throughout the experiment and arterial pressure was measured regularly using a sphygmomanometer. An isotonic solution (Compound Sodium Lactate Injection B.P.) was infused via a cannula placed in a hind limb vein and the rate adjusted to deliver 100 ml h -1 . Samples for blood-gas analysis and gamma counting were removed via a cannula inserted in a forelimb vein. Before measurement of effective renal plasma flow (ERPF), the bladder was completely emptied and the catheter occluded.
A gamma camera was positioned over the kidneys and 100 (xCi of 125 I-labelled hippuran was injected via the infusion cannula. Radioactivity over the kidneys was monitored continuously and renograms plotted by a computer (Nuclear Data). These plots were used as a qualitative assessment of renal perfusion and no dog was included in the study if its renal perfusion was inadequate. A quantitative estimate of renal blood flow was started concurrently and continued if the renogram was normal. Five-millilitre blood samples were collected at 1, 5, 10, 20, 30, 45, 60, 75 and 90 min after injection of 125 I-hippuran. All the urine was collected at the end of the 90-min period and the volume measured. The bladder was washed repeatedly with isotonic solution until no radioactivity remained. Urine and washings were added together and made up to a standard volume. Effective renal plasma flow was calculated using the single injection method with urine collection. The advantages of this method for estimating ERPF have been reviewed by O'Reilly, Shields and Testa (1979) . In each experiment two consecutive measurements of ERPF were obtained.
Each dog was assigned to one of the following plans of study on a random basis so arranged that each received the four treatments on four consecutive occasions:
(1) Twenty minutes infusion of dopamine 2 jxg kg min" 1 beginning 5 min before a second renogram and measurement of ERPF.
(2) Control infusion of isotonic solution in equivalent volumes. (3) Droperidol 0.2 mg kg" 1 injected i.v. just after induction of anaesthesia followed by a 20-min infusion of dopamine as in (1). (4) Droperidol injected as above with a control infusion as in (2).
The effects of dopamine or control infusion on ERPF were expressed as percentage change from the first ERPF measured during the same experiment. Significance of differences between treatments was calculated using a nested analysis of variance, otherwise a paired t test was used. Results are expressed as means + SD.
Each dog was allowed 2-4 weeks for recovery between experiments.
The total dose of fentanyl administered did not differ significantly in the four treatments (table I) .
RESULTS
Only one dog was rejected because of inadequate renal perfusion. This was demonstrated by widening of the renogram curve and slow build up of radioactivity in the bladder ( fig. 1 ).
The addition of droperidol to the anaesthetic regimen did not significantly alter ERPF measured in this study (table I) . Dopamine 2 (xg kg" 1 min" 1 produced significantly greater ERPF than the control infusion, but this was abolished when droperidol was present (table II) . (The nested analysis of variance showed that the ERPF was significantly altered by the nature of the infusion rather than by the anaesthetic used.) Heart rate, arterial pressure and rectal temperature were not significantly different in the groups of dogs receiving anaesthesia with or without droperidol (table I) . We confirmed in this study that the dose of dopamine used had no effect on the heart rate and arterial pressure. The maximum change in systolic arterial pressure which occurred during the dopamine infusion was -1.13 + 2.08 kPa and the maximum heart rate change was -6.8 + 5.1 beat min"
1 . These changes were not significantly different from those measured during the control infusion.
The change in urine volume from the first and second estimation suggests that droperidol did not inhibit the effects of dopamine in this respect (table  II) . However, the urine output was extremely variable, sometimes only small quantities being collected over a 90-min period. All the dogs which received a standard anaesthetic and dopamine showed an increase in urine volume (range +1.0 to +192.5 ml). Two dogs in the droperidol-treated group showed a decrease in urine output (range for all six dogs -30 to 118 ml).
DISCUSSION
We have confirmed that a 20-min infusion of dopamine 2 jig kg" 1 min" 1 improves ERPF in the dog. Furthermore, we have demonstrated that droperidol O^mgkg-1 abolishes this effect. There was no evidence that droperidol alone had any effect on ERPF at this dose.
Whilst it was not possible to demonstrate that droperidol significantly reduced the increase in urine volume produced by dopamine, the addition of droperidol to the anaesthetic made the response to dopamine less predictable. In man, Birch and Boyce (1977) found that droperidol did not attenuate the effect of an infusion of dopamine 20 ng kg" 1 min" 1 . However, as pointed out by Zimmerman (1978) , this dose of dopamine was too great to produce renal vasodilatation by a specific dopaminergic mechanism. A more selective dose of dopamine was used in man and dogs by Goto, Fujita and Fuse (1979) . These authors found that droperidol apparently increased the effects of dopamine on urine flow and the excretion of sodium and inorganic phosphate. The findings in the present study suggest that droperidol may attenuate the effect of dopamine on urine volume. There was no suggestion that droperidol increased urine volume. These differences may be explained by the timing of the droperidol administration. Goto, Fujita and Fuse (1979) administered droperidolat the time of the dopamine infusion in dogs. In the present study, in order to simulate clinical practice, droperidol was administered at induction of anaesthesia, a minimum of 2 h before the administration of dopamine.
The accepted clinical dose of droperidol is 0.07-O.Smgkgr 1 (Morgan, Lumley and Gillies, 1974) . Thus, the dose of droperidol used in this study which attenuated the effects of dopamine was well within the clinical range.
Our investigation in dogs indicates that the use of small-dose dopamine infusions to increase renal blood flow may be ineffective in patients given droperidol some hours previously. A carefully controlled study in man is needed to confirm this. selective usada en neuroleptanestesia, puede atenuar esta respuesta. El flujo efectivo de plasma renal se midi6 de forma no invasora, usando m I-hipuran. Una infusi6n de 2 ng kg~x mm-1 de dopamina durante 20 minutos increment6 el flujo efectivo de plasma renal (incremento medio del 16%) (P<0,05), en perros anestesiados. Este efecto *e anul6 (disminucion media del 6,6%), mediante el uso de 0,2 mg kg' 1 de dropcridol, administrado al principio de la anestesia. La conclusion es que cl dropcridol reduce la Hflamr-iAn de los vasos renales, que indujo la dopamina en lot perros anestesiados.
